Inhibition of human erythrocyte (Na+-K+)ATPase by organic hydroperoxides and protection by ascorbic acid and butylated hydroxytoluene

General Pharmacology

Volumn 30, Issue 4, 1998, Pages 495-498

  Yeşilkaya, Akin ^a   Yegin, Ayşenur ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

(Na+ K+)ATPase; Ascorbic acid; Butylated hydroxytoluene; Erythrocyte membrane; Organic hydroperoxides

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIOXIDANT; ASCORBIC ACID; BUTYLCRESOL; CUMENE HYDROPEROXIDE; TERT BUTYL HYDROPEROXIDE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIOXIDANTS; ASCORBIC ACID; BUTYLATED HYDROXYTOLUENE; ERYTHROCYTES; HUMANS; HYDROGEN PEROXIDE; NA(+)-K(+)-EXCHANGING ATPASE;

EID: 0032053973     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00285-1     Document Type: Article

References (16)

1. Burk R. F., Ludden T. M. Exhales alkanes as indices of in vivo lipid peroxidation. Biochem Pharmac. 38:1989;1029-1032.
2. Clemens M. R., Waller H. D. Lipid peroxidation in erythrocytes. Chem. Phys. Lipids. 45:1987;251-268.
3. Frei B., Stocker R., Ames B. N. Antioxidant defences and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85:1988;9748-9752.
4. Gutteridge J. M. C., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 15:1990;129-134.
5. Halliwell B., Gutteridge J. M. C. Role of free radicals and catalytic metal ions in human disease. an overview Methods Enzymol. 186:1990;1-85.
6. +-ATPase and membrane and serum lipid profiles. as related to alcohol, body mass index and blood pressure Clin. Exp. Hypertens. 16:1994;741-759.
7. Lehninger A. L., Nelson D. L., Cox M. M. Principles of Biochemistry. 1993;Worth, New York. pp. 268-297.
8. +-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes. 43:1994;915-919.
9. +-pump ATPase by iron-generated free radicals. protection by 6,7-dimethyl-2,4-DI-1-pyrrolidinyl-7H-pyrrolo[2,3-d] pyrimidine sulfate (U-89843D), a potent, novel, antioxidant/free radical scavenger Biochem. Pharmac. 51:1996;471-476.
10. Saltman P. Oxidative stress. a radical view Sem. Hematol. 26:1989;249-256.
11. Smith J. A., Baker M. S., Weidemann M. J. Free radical generation in hydroperoxide-treated erythrocytes monitored continuously by luminol-amplified chemiluminescence. Biochem. Int. 28:1992;1009-1020.
12. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N., Ames B. N. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
13. Van der Zee J., Van Steveninck J., Koster J. F., Dubbelman T. M. A. R. Inhibition of enzymes and oxidative damage of red blood cells induced by t-butylhydroperoxide-derived radicals. Biochem. Biophys. Acta. 980:1989;175-180.
14. Yalçin A. S., Sabuncu N., Emerk K. Chemiluminescence measurements as an indicator of cumene hydroperoxide-induced lipid peroxidation in human erythrocytes. Hematol. Rev. 4:1990;147-150.
15. Yalçin A. S., Sabuncu N., Emerk K. Cumene hydroperoxide-induced chemiluminescence in human erythrocytes. effect of antioxidants and sulphydryl compounds Int. J. Biochem. 24:1992;499-502.
16. Yeşilkaya A., Yegin A., Yücel G., Alicigüzel Y., Aksu T. A. Continuous monitoring of hydroperoxide-induced peroxidation in human erythrocytes by low-level chemiluminescence. Int. J. Clin. Lab. Res. 26:1996;60-68.